학술논문
Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
Document Type
Article
Author
Source
In eClinicalMedicine June 2023 60
Subject
Language
ISSN
2589-5370